Replimune Group, Inc. (REPL) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 12.52 |
| FCF Yield | -41.3% |
| Sector P/E (Healthcare) | 21.6 |
REPL overview · REPL earnings · REPL KPIs · REPL investor relations · REPL ownership · REPL peers · REPL filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.